Up to 600 children in the first year and 2,000 the year after will be among first in Europe to receive Palforzia treatment
Children in the UK will be the first in Europe to receive a life-changing treatment for peanut allergies, after NHS England secured a deal for a drug that decreases the severity of symptoms including anaphylaxis.
The oral treatment, Palforzia, will be available to up to 600 children aged four to 17 the first year and 2,000 the following year.
